<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="mt-overview" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">mt-overview</book-part-id>
      <title-group>
        <title>Mitochondrial Disorders Overview</title>
        <alt-title alt-title-type="alt-title">Synonyms: Mitochondrial Encephalomyopathies, Mitochondrial Myopathies, Oxidative Phosphorylation Disorders, Respiratory Chain Disorders</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chinnery</surname>
            <given-names>Patrick F</given-names>
          </name>
          <degrees>BMedSci, MBBS, PhD, FRCPath, FRCP, FMedSci</degrees>
          <aff>Department of Clinical Neurosciences<break/>University of Cambridge<break/>Cambridge, United Kingdom</aff>
          <email>pfc25@medschl.cam.ac.uk</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>8</day>
          <month>6</month>
          <year>2000</year>
        </date>
        <date date-type="updated">
          <day>14</day>
          <month>8</month>
          <year>2014</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="narp" document-type="chapter">Mitochondrial DNA-Associated Leigh Syndrome and NARP</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="mt-mpan" document-type="chapter">Mitochondrial Membrane Protein-Associated Neurodegeneration</related-object>
      <abstract id="mt-overview.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Mitochondrial diseases are a clinically heterogeneous group of disorders that arise as a result of dysfunction of the mitochondrial respiratory chain. They can be caused by mutation of genes encoded by either nuclear DNA or mitochondrial DNA (mtDNA). While some mitochondrial disorders only affect a single organ (e.g., the eye in Leber hereditary optic neuropathy [LHON]), many involve multiple organ systems and often present with prominent neurologic and myopathic features. Mitochondrial disorders may present at any age. Many individuals with a mutation of mtDNA display a cluster of clinical features that fall into a discrete clinical syndrome, such as the Kearns-Sayre syndrome (KSS), chronic progressive external ophthalmoplegia (CPEO), mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS), myoclonic epilepsy with ragged-red fibers (MERRF), neurogenic weakness with ataxia and retinitis pigmentosa (NARP), or Leigh syndrome (LS). However, considerable clinical variability exists and many individuals do not fit neatly into one particular category, which is well-illustrated by the overlapping spectrum of disease phenotypes (including mitochondrial recessive ataxia syndrome (MIRAS) resulting from mutation of the nuclear gene <italic toggle="yes">POLG</italic>, which has emerged as a major cause of mitochondrial disease. Common clinical features of mitochondrial disease &#x02013; whether involving a mitochondrial or nuclear gene &#x02013; include ptosis, external ophthalmoplegia, proximal myopathy and exercise intolerance, cardiomyopathy, sensorineural deafness, optic atrophy, pigmentary retinopathy, and diabetes mellitus. Common central nervous system findings are fluctuating encephalopathy, seizures, dementia, migraine, stroke-like episodes, ataxia, and spasticity. A high incidence of mid- and late pregnancy loss is a common occurrence that often goes unrecognized.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>In some individuals, the clinical picture is characteristic of a specific mitochondrial disorder (e.g., LHON, NARP, or maternally inherited LS), and the diagnosis can be confirmed by identification of a pathogenic mtDNA variant on molecular genetic testing of DNA extracted from a blood sample. In many individuals, such is not the case, and a more structured approach is needed, including family history, blood and/or CSF lactate concentration, neuroimaging, cardiac evaluation, and molecular genetic testing for a mtDNA or nuclear gene pathogenic variant. Approaches to molecular genetic testing of a proband to consider are serial testing of single genes, multi-gene panel testing (simultaneous testing of multiple genes), and/or genomic testing (e.g., sequencing of the entire mitochondrial genome, genome sequencing, or exome sequencing to identify a pathogenic variant in a nuclear gene). In many individuals in whom molecular genetic testing does not yield or confirm a diagnosis, further investigation of suspected mitochondrial disease can involve a range of different clinical tests, including muscle biopsy for respiratory chain function.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Mitochondrial disorders may be caused by defects of nuclear DNA or mtDNA. Nuclear gene defects may be inherited in an autosomal recessive or autosomal dominant manner. Mitochondrial DNA defects are transmitted by maternal inheritance. Mitochondrial DNA deletions generally occur <italic toggle="yes">de novo</italic> and thus cause disease in one family member only, with an approximate recurrence risk of 1 in 24. Mitochondrial DNA single-nucleotide variants and duplications may be transmitted down the maternal line. The father of a proband is not at risk of having the mtDNA pathogenic variant, but the mother of a proband (usually) has the mitochondrial pathogenic variant and may or may not have symptoms. A male does not transmit the mtDNA pathogenic variant to his offspring. A female harboring a heteroplasmic mtDNA single-nucleotide variant may transmit a variable amount of mutated mtDNA to her offspring, resulting in considerable clinical variability among sibs within the same family. Prenatal genetic testing and interpretation of test results for mtDNA disorders are difficult because of mtDNA heteroplasmy. <italic toggle="yes">De novo</italic> tissue-specific pathogenic nucleotide variants are rare, but associated with low recurrence risks.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> The management of mitochondrial disease is largely supportive and may include early diagnosis and treatment of diabetes mellitus, cardiac pacing, ptosis correction, intraocular lens replacement for cataracts, and cochlear implantation for sensorineural hearing loss. Individuals with complex I and/or complex II deficiency may benefit from oral administration of riboflavin; those with ubiquinone (coenzyme Q<sub>10</sub>) deficiency may benefit from oral coenzyme Q<sub>10</sub> therapy; and those with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) may benefit from hematopoietic stem cell transplantation.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="mt-overview.Definition">
        <title>Definition</title>
        <p>Mitochondrial diseases are a clinically heterogeneous group of disorders that arise as a result of dysfunction of the mitochondrial respiratory chain. The mitochondrial respiratory chain is the essential final common pathway for aerobic metabolism, and tissues and organs that are highly dependent on aerobic metabolism are preferentially involved in mitochondrial disorders [<xref ref-type="bibr" rid="mt-overview.REF.wallace.1999.1482">Wallace 1999</xref>].</p>
        <p>More than 70 different polypeptides interact on the inner mitochondrial membrane to form the respiratory chain. The vast majority of subunits are synthesized within the cytosol from nuclear gene transcripts, but 13 essential subunits are encoded by the 16.5-kb mitochondrial DNA (mtDNA) [<xref ref-type="bibr" rid="mt-overview.REF.larsson.1995.151">Larsson &#x00026; Clayton 1995</xref>].</p>
        <p><xref ref-type="fig" rid="mt-overview.F1">Figure 1</xref> illustrates the structure of the human mitochondrial genome.</p>
        <list list-type="bullet">
          <list-item>
            <p>The 1.1-kb D-loop (noncoding region) is involved in the regulation of transcription and replication of the molecule, and is the only region not directly involved in the synthesis of respiratory chain polypeptides.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">MT-ND1</italic> through <italic toggle="yes">MT-ND6</italic> and <italic toggle="yes">MT-ND4L</italic> encode seven subunits of complex I.</p>
          </list-item>
          <list-item>
            <p>Cyt b is the only mtDNA-encoded complex III subunit.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">MT-CO1</italic> to <italic toggle="yes">MT-CO3</italic> encode for three of the complex IV (cytochrome c oxidase, or COX) subunits.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">MT-ATP6</italic> and <italic toggle="yes">MT-ATP8</italic> encode for two subunits of complex V: ATPase6 and ATPase8, respectively.</p>
          </list-item>
          <list-item>
            <p>Two ribosomal RNA genes (<italic toggle="yes">MT-RNR1</italic> and <italic toggle="yes">MT-RNR2</italic>, encoding 12S and 16S rRNA) and 22 transfer RNA genes are interspaced between the protein-encoding genes. These provide the necessary RNA components for intra-mitochondrial protein synthesis.</p>
          </list-item>
          <list-item>
            <p>O<sub>H</sub> and O<sub>L</sub> are the origins of heavy- and light-strand mtDNA replication.</p>
          </list-item>
        </list>
        <p>Each human cell contains thousands of copies of mtDNA. At birth these are usually all identical (homoplasmy). By contrast, individuals with mitochondrial disorders resulting from mutation of mtDNA may harbor a mixture of mutated and wild-type mtDNA within each cell (heteroplasmy) [<xref ref-type="bibr" rid="mt-overview.REF.holt.1988.717">Holt et al 1988</xref>, <xref ref-type="bibr" rid="mt-overview.REF.holt.1990.428">Holt et al 1990</xref>]. Single-cell studies and cybrid-cell studies have shown that the proportion of mutated mtDNA must exceed a critical threshold level before a cell expresses a biochemical abnormality of the mitochondrial respiratory chain (the threshold effect) [<xref ref-type="bibr" rid="mt-overview.REF.schon.1997.131">Schon et al 1997</xref>]. The percentage level of mutated mtDNA may vary among individuals within the same family, and also among organs and tissues within the same individual [<xref ref-type="bibr" rid="mt-overview.REF.macmillan.1993.1586">Macmillan et al 1993</xref>]. This is one explanation for the varied clinical phenotype seen in individuals with disorders caused by mutation of mtDNA. For example, in individuals harboring the <xref ref-type="table" rid="mt-overview.T.genetic_classification_of_1">m.8993T&#x0003e;G</xref> pathogenic variant, higher percentage levels of mutated mtDNA are seen in those presenting with Leigh syndrome than in those presenting with neurogenic weakness with ataxia and retinitis pigmentosa (NARP) [<xref ref-type="bibr" rid="mt-overview.REF.uziel.1997.16">Uziel et al 1997</xref>, <xref ref-type="bibr" rid="mt-overview.REF.white.1999a.474">White et al 1999a</xref>].</p>
        <p>Other important mitochondrial mechanisms controlled by nuclear genes include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Disorders of mtDNA maintenance (mtDNA depletion or secondary pathogenic mtDNA variants);</p>
          </list-item>
          <list-item>
            <p>Disorders of mitochondrial protein synthesis;</p>
          </list-item>
          <list-item>
            <p>Disorders of coenzyme Q<sub>10</sub> biosynthesis;</p>
          </list-item>
          <list-item>
            <p>Disorders of the respiratory chain complexes or their assembly.</p>
          </list-item>
        </list>
        <p>With more than 1000 nuclear genes encoding mitochondrial proteins, the molecular diagnosis can be challenging.</p>
        <p><bold>Secondary mitochondrial dysfunction in human diseases.</bold> Mitochondrial dysfunction is also seen in a number of different genetic disorders, including <related-object link-type="booklink" source-id="gene" document-id="ee" document-type="chapter">ethylmalonic aciduria</related-object> (caused by mutation of <italic toggle="yes">ETHE1</italic>) [<xref ref-type="bibr" rid="mt-overview.REF.tiranti.2009.200">Tiranti et al 2009</xref>], <related-object link-type="booklink" source-id="gene" document-id="friedreich" document-type="chapter">Friedreich ataxia</related-object> (<italic toggle="yes">FXN</italic>) [<xref ref-type="bibr" rid="mt-overview.REF.r_tig.1997.215">R&#x000f6;tig et al 1997</xref>], <related-object link-type="booklink" source-id="gene" document-id="spg7" document-type="chapter">hereditary spastic paraplegia 7</related-object> (<italic toggle="yes">SPG7</italic>) [<xref ref-type="bibr" rid="mt-overview.REF.casari.1998.973">Casari et al 1998</xref>], and <related-object link-type="booklink" source-id="gene" document-id="wilson" document-type="chapter">Wilson disease</related-object> (<italic toggle="yes">ATP7B</italic>) [<xref ref-type="bibr" rid="mt-overview.REF.lutsenko.1998.6004">Lutsenko &#x00026; Cooper 1998</xref>], and is also seen as part of the aging process. These are not strictly mitochondrial diseases. The term mitochondrial disorder usually refers to primary disorders of mitochondrial metabolism affecting oxidative phosphorylation.</p>
        <sec id="mt-overview.Clinical_Manifestations">
          <title>Clinical Manifestations</title>
          <p>Some mitochondrial disorders affect a single organ (e.g., the eye in <related-object link-type="booklink" source-id="gene" document-id="lhon" document-type="chapter">Leber hereditary optic neuropathy</related-object> and the ear in nonsyndromic hearing loss with or without aminoglycoside sensitivity; see <related-object link-type="booklink" source-id="gene" document-id="mt-deafness" document-type="chapter">Mitochondrial Hearing Loss and Deafness</related-object>), but many involve multiple organ systems and often present with prominent neurologic and myopathic features.</p>
          <p>Mitochondrial disorders may present at any age [<xref ref-type="bibr" rid="mt-overview.REF.leonard.2000a.299">Leonard &#x00026; Schapira 2000a</xref>, <xref ref-type="bibr" rid="mt-overview.REF.leonard.2000b.389">Leonard &#x00026; Schapira 2000b</xref>]. Until recently it was generally thought that nuclear DNA abnormalities present in childhood and mtDNA abnormalities (primary or secondary to a nuclear DNA abnormality) present in late childhood or adult life; however, recent advances have shown that many mtDNA disorders present in childhood, and many nuclear genetic mitochondrial disorders present in adult life.</p>
          <p>Many individuals display a cluster of clinical features that fall into a discrete clinical syndrome (<xref ref-type="table" rid="mt-overview.T.clinical_syndromes_of_mito">Table 1</xref>) [<xref ref-type="bibr" rid="mt-overview.REF.dimauro.2001.18">DiMauro &#x00026; Schon 2001</xref>, <xref ref-type="bibr" rid="mt-overview.REF.munnich.2001.4">Munnich &#x00026; Rustin 2001</xref>], such as <related-object link-type="booklink" source-id="gene" document-id="kss" document-type="chapter">Kearns-Sayre syndrome</related-object> (KSS), <related-object link-type="booklink" source-id="gene" document-id="kss" document-type="chapter">chronic progressive external ophthalmoplegia</related-object> (CPEO) [<xref ref-type="bibr" rid="mt-overview.REF.moraes.1989.1293">Moraes et al 1989</xref>], mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (<related-object link-type="booklink" source-id="gene" document-id="melas" document-type="chapter">MELAS</related-object>) [<xref ref-type="bibr" rid="mt-overview.REF.hirano.1992.125">Hirano et al 1992</xref>], myoclonic epilepsy with ragged-red fibers (<related-object link-type="booklink" source-id="gene" document-id="merrf" document-type="chapter">MERRF</related-object>) [<xref ref-type="bibr" rid="mt-overview.REF.hammans.1993.617">Hammans et al 1993</xref>], neurogenic weakness with ataxia and retinitis pigmentosa (<related-object link-type="booklink" source-id="gene" document-id="narp" document-type="chapter">NARP</related-object>) [<xref ref-type="bibr" rid="mt-overview.REF.holt.1990.428">Holt et al 1990</xref>], or <related-object link-type="booklink" source-id="gene" document-id="narp" document-type="chapter">Leigh syndrome</related-object> (LS) [<xref ref-type="bibr" rid="mt-overview.REF.ciafaloni.1993.419">Ciafaloni et al 1993</xref>]. However, there is often considerable clinical variability and many affected individuals do not fit neatly into one particular category. Mutation of <italic toggle="yes">POLG</italic>, which has emerged as a major cause of mitochondrial disease, illustrates this well, with an overlapping spectrum of disease phenotypes resulting from pathogenic variants in the same gene (see <related-object link-type="booklink" source-id="gene" document-id="alpers" document-type="chapter"><italic toggle="yes">POLG</italic>-Related Disorders</related-object>).</p>
          <p>Common clinical features of mitochondrial disease include ptosis, external ophthalmoplegia, proximal myopathy and exercise intolerance, cardiomyopathy, sensorineural deafness, optic atrophy, pigmentary retinopathy, and diabetes mellitus. Diabetes mellitus and deafness is also a well-recognized clinical phenotype [<xref ref-type="bibr" rid="mt-overview.REF.van_den_ouweland.1992.368">van den Ouweland et al 1992</xref>].</p>
          <p>The central nervous system findings are often fluctuating encephalopathy, seizures, dementia, migraine, stroke-like episodes, ataxia, and spasticity. Chorea and dementia may also be prominent features [<xref ref-type="bibr" rid="mt-overview.REF.nelson.1995.400">Nelson et al 1995</xref>].</p>
          <p>A high incidence of mid- and late pregnancy loss is also a common feature that often remains unrecognized [<xref ref-type="bibr" rid="mt-overview.REF.tay.2004.950">Tay et al 2004</xref>].</p>
          <table-wrap id="mt-overview.T.clinical_syndromes_of_mito" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Clinical Syndromes of Mitochondrial Diseases</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Disorder</th>
                  <th id="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Primary Features</th>
                  <th id="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Additional Features</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <related-object link-type="booklink" source-id="gene" document-id="alpers" document-type="chapter">Alpers-Huttenlocher syndrome</related-object>
                  </td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Hypotonia<break/>Seizures<break/>Liver failure</td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Renal tubulopathy</td>
                </tr>
                <tr>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="alpers" document-type="chapter">Ataxia neuropathy syndromes</related-object> (ANS): Including MIRAS, SCAE, SANDO, MEMSA</td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">SANDO<break/>Other ANS: Sensory axonal neuropathy w/variable sensory &#x00026; cerebellar ataxia</td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Epilepsy<break/>Dysarthria, and/or<break/>Myopathy</td>
                </tr>
                <tr>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <related-object link-type="booklink" source-id="gene" document-id="kss" document-type="chapter">CPEO</related-object>
                  </td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">External ophthalmoplegia<break/>Bilateral ptosis</td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Mild proximal myopathy</td>
                </tr>
                <tr>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <related-object link-type="booklink" source-id="gene" document-id="kss" document-type="chapter">KSS</related-object>
                  </td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">PEO onset at age &#x0003c;20 years<break/>Pigmentary retinopathy<break/>One of the following: CSF protein &#x0003e;1g/L, cerebellar ataxia, heart block</td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Bilateral deafness<break/>Myopathy<break/>Dysphagia<break/>Diabetes mellitus<break/>Hypoparathyroidism<break/>Dementia</td>
                </tr>
                <tr>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <related-object link-type="booklink" source-id="gene" document-id="kss" document-type="chapter">Pearson syndrome</related-object>
                  </td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sideroblastic anemia of childhood<break/>Pancytopenia<break/>Exocrine pancreatic failure</td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Renal tubular defects</td>
                </tr>
                <tr>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Infantile myopathy and lactic acidosis (fatal &#x00026; non-fatal forms)</td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Hypotonia in 1st year of life<break/>Feeding &#x00026; respiratory difficulties</td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Fatal form may be associated with a cardiomyopathy and/or the Toni-Fanconi-Debre syndrome</td>
                </tr>
                <tr>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <related-object link-type="booklink" source-id="gene" document-id="narp" document-type="chapter">Leigh syndrome</related-object>
                  </td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Subacute relapsing encephalopathy<break/>Cerebellar and brain stem signs<break/>Infantile onset</td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Basal ganglia lucencies<break/>Maternal history of neurologic disease or Leigh syndrome</td>
                </tr>
                <tr>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <related-object link-type="booklink" source-id="gene" document-id="narp" document-type="chapter">NARP</related-object>
                  </td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Late-childhood or adult-onset peripheral neuropathy<break/>Ataxia<break/>Pigmentary retinopathy</td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Basal ganglia lucencies<break/>Abnormal electroretinogram<break/>Sensorimotor neuropathy</td>
                </tr>
                <tr>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <related-object link-type="booklink" source-id="gene" document-id="melas" document-type="chapter">MELAS</related-object>
                  </td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Stroke-like episodes at age &#x0003c;40 years<break/>Seizures and/or dementia<break/>Ragged-red fibers and/or lactic acidosis</td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Diabetes mellitus<break/>Cardiomyopathy (initially hypertrophic; later dilated)<break/>Bilateral deafness<break/>Pigmentary retinopathy<break/>Cerebellar ataxia</td>
                </tr>
                <tr>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="alpers" document-type="chapter">MEMSA</related-object>&#x000a0;<sup>1</sup></td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Myopathy<break/>Seizures<break/>Cerebellar ataxia</td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Dementia<break/>Peripheral neuropathy<break/>Spasticity</td>
                </tr>
                <tr>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <related-object link-type="booklink" source-id="gene" document-id="merrf" document-type="chapter">MERRF</related-object>
                  </td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Myoclonus<break/>Seizures<break/>Cerebellar ataxia<break/>Myopathy</td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Dementia<break/>Optic atrophy<break/>Bilateral deafness<break/>Peripheral neuropathy<break/>Spasticity<break/>Multiple lipomata</td>
                </tr>
                <tr>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <related-object link-type="booklink" source-id="gene" document-id="lhon" document-type="chapter">LHON</related-object>
                  </td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Subacute painless bilateral visual failure<break/>Males:females ~4:1<break/>Median age of onset 24 years</td>
                  <td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Dystonia<break/>Cardiac pre-excitation syndromes</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>CPEO = chronic progressive external ophthalmoplegia</p>
              </fn>
              <fn>
                <p>KSS = Kearns-Sayre syndrome</p>
              </fn>
              <fn>
                <p>LHON = Leber hereditary optic neuropathy</p>
              </fn>
              <fn>
                <p>MELAS = mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes</p>
              </fn>
              <fn>
                <p>MEMSA = myoclonic epilepsy myopathy sensory ataxia</p>
              </fn>
              <fn>
                <p>MERRF = myoclonic epilepsy with ragged-red fibers</p>
              </fn>
              <fn>
                <p>MIRAS = mitochondrial recessive ataxia syndrome</p>
              </fn>
              <fn>
                <p>NARP = neurogenic weakness with ataxia and retinitis pigmentosa</p>
              </fn>
              <fn>
                <p>SANDO = sensory ataxia neuropathy, dysarthria, ophthalmoplegia</p>
              </fn>
              <fn>
                <p>SCAE = spinocerebellar ataxia with epilepsy</p>
              </fn>
              <fn id="mt-overview.TF.1.1">
                <label>1. </label>
                <p>Also referred to as MIRAS and SCAE</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="mt-overview.Differential_Diagnosis">
          <title>Differential Diagnosis</title>
          <p><bold>Lactic acidosis.</bold> It is important to exclude other causes of lactic acidosis when interpreting these values. For example, the concentration of lactate may be elevated in the plasma and CSF of affected individuals following a seizure. CSF lactate concentration may be elevated following an ischemic stroke.</p>
          <p><bold>White matter abnormalities.</bold> See <xref ref-type="bibr" rid="mt-overview.REF.scarpelli.2013.520">Scarpelli et al [2013]</xref>, <xref ref-type="bibr" rid="mt-overview.REF.morat_.2014.1878">Morat&#x000f3; et al [2014]</xref>, and <xref ref-type="bibr" rid="mt-overview.REF.wu.2016.1034">Wu et al [2016]</xref>.</p>
        </sec>
        <sec id="mt-overview.Prevalence">
          <title>Prevalence</title>
          <p>Mitochondrial disorders are more common than was previously thought (<xref ref-type="table" rid="mt-overview.T.epidemiology_of_mitochondr">Table 2</xref>). Based on the available data, a conservative estimate for the prevalence of all mitochondrial diseases is 11.5:100,000 (~1:8500). <xref ref-type="bibr" rid="mt-overview.REF.arpa.2003.690">Arpa et al [2003]</xref> calculated prevalence in Spain at 5.7:100,000 for individuals older than age 14 years.</p>
          <table-wrap id="mt-overview.T.epidemiology_of_mitochondr" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Epidemiology of Mitochondrial Disease</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Study Population</th>
                  <th id="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Pathogenic Variant or Disease</th>
                  <th id="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Disease Prevalence / 100,000<break/>(95% C.I.)&#x000a0;<sup>1</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_1" rowspan="6" valign="middle" align="left" scope="row" colspan="1">Northern England&#x000a0;<sup>2</sup>
<list list-type="bullet"><list-item><p>Point prevalence August 1997</p></list-item><list-item><p>Population size: 2,122,290</p></list-item></list>
</td>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">All mtDNA deletions</td>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1.33&#x000a0;<sup>3</sup>
<break/>(0.76-1.89)</td>
                </tr>
                <tr>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">All mtDNA single nucleotide variants</td>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">5.24&#x000a0;<sup>3</sup>
<break/>(4.12-6.37)</td>
                </tr>
                <tr>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.11778G&#x0003e;A, m.3460G&#x0003e;A (LHON)</td>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">3.29&#x000a0;<sup>3</sup>
<break/>(2.39-4.18)</td>
                </tr>
                <tr>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.3243A&#x0003e;G</td>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">0.95&#x000a0;<sup>3</sup>
<break/>(0.47-1.43)</td>
                </tr>
                <tr>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.8344A&#x0003e;G</td>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">0.25&#x000a0;<sup>3</sup>
<break/>(0.01-0.5)</td>
                </tr>
                <tr>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">All pathogenic mtDNA variants</td>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">6.57&#x000a0;<sup>4</sup>
<break/>(5.30-7.83)</td>
                </tr>
                <tr>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Northern Finland&#x000a0;<sup>5</sup>
<list list-type="bullet"><list-item><p>Adult point prevalence</p></list-item><list-item><p>Population size: 245,201</p></list-item></list>
</td>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">m.3243A&#x0003e;G</td>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">5.71 <break/>(4.53-6.89)</td>
                </tr>
                <tr>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Western Sweden&#x000a0;<sup>6</sup>
<list list-type="bullet"><list-item><p>Children age &#x0003c;16: 385,616</p></list-item></list>
</td>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Childhood mitochondrial encephalomyopathies</td>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">4.7&#x000a0;<sup>7</sup>
<break/>(2.8-7.6)</td>
                </tr>
                <tr>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Victoria, Australia&#x000a0;<sup>8</sup>
<list list-type="bullet"><list-item><p>Birth prevalence: 1,710,000 births</p></list-item></list>
</td>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Childhood respiratory chain disease</td>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">4.7&#x000a0;<sup>9</sup>
<break/>(3.2-5.0)</td>
                </tr>
                <tr>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Summary</td>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mitochondrial disease (adults and children)</td>
                  <td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~11.5</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note: The mitochondrial genetic code varies from the genomic genetic code given in the <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object>. For the genetic code, gene structure, and other features of the mitochondrial genome see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.mitomap.org/MITOMAP">MITOMAP: A Human Mitochondrial Genome Database</ext-link>. Variants are named according to current nomenclature guidelines (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). The reference sequence for the human mitochondrial DNA is <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NC_012920.1">NC_012920.1</ext-link> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.mitomap.org">www.mitomap.org</ext-link>).</p>
              </fn>
              <fn id="mt-overview.TF.2.1">
                <label>1.&#x000a0;</label>
                <p>C.I. = confidence interval</p>
              </fn>
              <fn id="mt-overview.TF.2.2">
                <label>2. </label>
                <p>
                  <xref ref-type="bibr" rid="mt-overview.REF.chinnery.2000.188">Chinnery et al [2000]</xref>
                </p>
              </fn>
              <fn id="mt-overview.TF.2.3">
                <label>3.&#x000a0;</label>
                <p>The prevalence of mtDNA disease is based on affected adults (age 16-65 yrs for males; 16-60 yrs for females).</p>
              </fn>
              <fn id="mt-overview.TF.2.4">
                <label>4.&#x000a0;</label>
                <p>The prevalence of mtDNA pathogenic variants is based on all individuals under retirement age (&#x0003c;65 yrs for males; &#x0003c;60 yrs for females).</p>
              </fn>
              <fn id="mt-overview.TF.2.5">
                <label>5. </label>
                <p>
                  <xref ref-type="bibr" rid="mt-overview.REF.majamaa.1998.447">Majamaa et al [1998]</xref>
                </p>
              </fn>
              <fn id="mt-overview.TF.2.6">
                <label>6. </label>
                <p>
                  <xref ref-type="bibr" rid="mt-overview.REF.darin.2001.377">Darin et al [2001]</xref>
                </p>
              </fn>
              <fn id="mt-overview.TF.2.7">
                <label>7.&#x000a0;</label>
                <p>Point prevalence 1 January 1999</p>
              </fn>
              <fn id="mt-overview.TF.2.8">
                <label>8. </label>
                <p>
                  <xref ref-type="bibr" rid="mt-overview.REF.skladal.2003.1905">Skladal et al [2003]</xref>
                </p>
              </fn>
              <fn id="mt-overview.TF.2.9">
                <label>9.&#x000a0;</label>
                <p>Birth prevalence measured between 1987 and 1996</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="mt-overview.Causes">
        <title>Causes</title>
        <p>Mitochondrial disorders can be caused by mutation of nuclear DNA or mitochondrial DNA [<xref ref-type="bibr" rid="mt-overview.REF.koopman.2012.1132">Koopman et al 2012</xref>].</p>
        <p>The classification of mitochondrial disease is difficult. Although a purely clinical classification can be helpful (<xref ref-type="table" rid="mt-overview.T.clinical_syndromes_of_mito">Table 1</xref>), many individuals do not fall into one specific disease category. The situation is made all the more complex by the poor correlation between genotype and phenotype. For example, among a group of clinically indistinguishable individuals with external ophthalmoplegia, some may have a large deletion of mtDNA, others a single nucleotide variant of mtDNA (e.g., m.3243A&#x0003e;G), and still others a heterozygous pathogenic variant in a nuclear gene causing secondary mtDNA abnormalities (e.g., <italic toggle="yes">ANT1</italic> pathogenic variants).</p>
        <p>Recent advances in our understanding of the molecular genetic basis of mitochondrial disease have helped in the classification of these disorders by nuclear DNA mutation (<xref ref-type="table" rid="mt-overview.T.genetic_classification_of">Table 3a</xref>) and mitochondrial DNA mutation (<xref ref-type="table" rid="mt-overview.T.genetic_classification_of_1">Table 3b</xref>). Nonetheless, the genetic approach to classification also has certain drawbacks:</p>
        <list list-type="bullet">
          <list-item>
            <p>It is currently not possible to identify the pathogenic variant in a significant number of affected individuals, particularly children [<xref ref-type="bibr" rid="mt-overview.REF.lieber.2013.1762">Lieber et al 2013</xref>]</p>
          </list-item>
          <list-item>
            <p>The same pathogenic variant may cause a range of very different clinical syndromes (e.g., the m.3243A&#x0003e;G single nucleotide variant may cause CPEO, diabetes mellitus and deafness, or a severe encephalopathy with recurrent strokes and epilepsy).</p>
          </list-item>
          <list-item>
            <p>The rate of new gene discovery using genomic testing methods (e.g., exome sequencing) makes it difficult for any one resource to maintain a comprehensive list of all genes known to impair mitochondrial function.</p>
          </list-item>
        </list>
        <table-wrap id="mt-overview.T.genetic_classification_of" orientation="portrait" position="anchor">
          <label>Table 3a. </label>
          <caption>
            <p>Genetic Classification of Human Mitochondrial Disorders: Mutation of Nuclear DNA</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"/>
                <th id="hd_h_mt-overview.T.genetic_classification_of_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Mutation of Nuclear DNA</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Nuclear genetic disorders of the mitochondrial respiratory chain (mutated genes encoding structural subunits)&#x000a0;<sup>1</sup></bold>
                </td>
                <td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Leigh syndrome with complex I deficiency (<italic toggle="yes">NDUFS1, NDUFS4, NDUFS7, NDUFS8, NDUFV1</italic>)<break/>Leigh syndrome with complex II deficiency (<italic toggle="yes">SDHA</italic>)<break/>Leukodystrophy with complex II deficiency (<italic toggle="yes">SDHAF1</italic>)<break/>Cardiomyopathy and encephalopathy (complex I deficiency) (<italic toggle="yes">NDUFS2</italic>)<break/>Optic atrophy and ataxia (complex II deficiency) (<italic toggle="yes">SDHA</italic>)<break/>Hypokalemia and lactic acidosis (complex III deficiency) (<italic toggle="yes">UQCRB</italic>)</td>
              </tr>
              <tr>
                <td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Nuclear genetic disorders of the mitochondrial respiratory chain (mutated genes encoding assembly factors)&#x000a0;<sup>1</sup></bold>
                </td>
                <td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Leigh syndrome (<italic toggle="yes">SURF1</italic>, <italic toggle="yes">LRPPRC</italic>)<break/>Hepatopathy and ketoacidosis (<italic toggle="yes">SCO1</italic>)<break/>Cardiomyopathy and encephalopathy (<italic toggle="yes">SCO2</italic>)<break/>Leukodystrophy and renal tubulopathy (<italic toggle="yes">COX10</italic>)<break/>Hypertrophic cardiomyopathy (<italic toggle="yes">COX15</italic>)<break/>Encephalopathy, liver failure, renal tubulopathy (with complex III deficiency) (<italic toggle="yes">BCS1L</italic>)<break/>Encephalopathy (with complex V deficiency) (<italic toggle="yes">ATPAF2</italic>)</td>
              </tr>
              <tr>
                <td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Nuclear genetic disorders of the mitochondrial respiratory chain (mutated genes encoding translation factors)&#x000a0;<sup>1</sup></bold>
                </td>
                <td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Leigh syndrome, liver failure, and lactic acidosis (<italic toggle="yes">GFM1</italic>)<break/>Lactic acidosis, developmental failure, and dysmorphism (<italic toggle="yes">MRPS16</italic>)<break/>Myopathy and sideroblastic anemia (<italic toggle="yes">PUS1</italic>)<break/>Leukodystrophy and polymicrogyria (<italic toggle="yes">TUFM</italic>)<break/>Leigh syndrome and optic atrophy with COX deficiency (<italic toggle="yes">TACO1</italic>)</td>
              </tr>
              <tr>
                <td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Nuclear genetic disorders associated with multiple mtDNA deletions or mtDNA depletion</bold>
                </td>
                <td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="alpers" document-type="chapter">Autosomal progressive external ophthalmoplegia</related-object> (<italic toggle="yes">POLG, POLG2, TWNK,</italic>
<italic toggle="yes">SLC25A4</italic>)<break/><related-object link-type="booklink" source-id="gene" document-id="mngie" document-type="chapter">Mitochondrial neurogastrointestinal encephalomyopathy</related-object> (thymidine phosphorylase deficiency) (<italic toggle="yes">TYMP</italic>)<break/><related-object link-type="booklink" source-id="gene" document-id="alpers" document-type="chapter">Alpers-Huttenlocher syndrome</related-object> (<italic toggle="yes">POLG</italic>)<break/>Ataxia neuropathy syndromes&#x000a0;<sup>2</sup> (<italic toggle="yes">POLG, TWNK, OPA1</italic>)<break/><related-object link-type="booklink" source-id="gene" document-id="tk2-mtddepl" document-type="chapter">Infantile myopathy / spinal muscular atrophy</related-object> (<italic toggle="yes">TK2</italic>)<break/><related-object link-type="booklink" source-id="gene" document-id="dguok-mtddepl" document-type="chapter">Encephalomyopathy and liver failure</related-object> (<italic toggle="yes">DGUOK</italic>)<break/><related-object link-type="booklink" source-id="gene" document-id="sucla2-def" document-type="chapter">Hypotonia, movement disorder, and/or Leigh syndrome with methylmalonic aciduria</related-object> (<italic toggle="yes">SUCLA2</italic>)<break/><related-object link-type="booklink" source-id="gene" document-id="rrm2b-mtddepl" document-type="chapter">Hypotonia, encephalopathy, renal tubulopathy, lactic acidosis</related-object> (<italic toggle="yes">RRM2B</italic>)<break/>Mitochondrial encephalomyopathy with combined RC deficiency (<italic toggle="yes">AIF1</italic>)<break/>Reversible hepatopathy (<italic toggle="yes">TRMU</italic>)<break/>Myopathy with cataract and combined RC deficiency (<italic toggle="yes">GFER</italic>)</td>
              </tr>
              <tr>
                <td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Other disorders</bold>
                </td>
                <td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="coq10-def" document-type="chapter">Coenzyme Q<sub>10</sub> deficiency</related-object> (<italic toggle="yes">COQ2, COQ9, CABC1, ETFDH</italic>)<break/><related-object link-type="booklink" source-id="gene" document-id="barth" document-type="chapter">Barth syndrome</related-object> (<italic toggle="yes">TAZ</italic>)<break/>Cardiomyopathy and lactic acidosis (mitochondrial phosphate carrier deficiency) (<italic toggle="yes">SLC25A3</italic>)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="mt-overview.TF.3a.1">
              <label>1. </label>
              <p>See <related-object link-type="booklink" source-id="gene" document-id="leigh-nucl-ov" document-type="chapter">Nuclear Gene-Encoded Leigh Syndrome Overview</related-object>.</p>
            </fn>
            <fn id="mt-overview.TF.3a.2">
              <label>2. </label>
              <p>Includes MIRAS, SCAE, SANDO, MEMSA</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap id="mt-overview.T.genetic_classification_of_1" orientation="portrait" position="anchor">
          <label>Table 3b. </label>
          <caption>
            <p>Genetic Classification of Human Mitochondrial Disorders: Mutation of Mitochondrial DNA</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"/>
                <th id="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Mutation of Mitochondrial DNA</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Rearrangements (deletions &#x00026; duplications)</bold>
                </td>
                <td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Chronic progressive external ophthalmoplegia<break/><related-object link-type="booklink" source-id="gene" document-id="kss" document-type="chapter">Kearns-Sayre syndrome</related-object><break/>Diabetes and deafness</td>
              </tr>
              <tr>
                <td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Single-nucleotide variants&#x000a0;<sup>1</sup></bold>
                </td>
                <td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Protein-encoding genes<break/><related-object link-type="booklink" source-id="gene" document-id="lhon" document-type="chapter">Leber hereditary optic neuropathy</related-object> (LHON) (m.11778G&#x0003e;A, m.14484T&#x0003e;C, m.3460G&#x0003e;A)<break/>Neurogenic weakness with ataxia and <related-object link-type="booklink" source-id="gene" document-id="rp-overview" document-type="chapter">retinitis pigmentosa</related-object> / <related-object link-type="booklink" source-id="gene" document-id="narp" document-type="chapter">Leigh syndrome</related-object> (m.8993T&#x0003e;G, m.8993T&#x0003e;C)</td>
              </tr>
              <tr>
                <td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>tRNA genes&#x000a0;<sup>1</sup></bold>
                </td>
                <td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="melas" document-type="chapter">MELAS</related-object> (m.3243A&#x0003e;G, m.3271T&#x0003e;C, m.3251A&#x0003e;G)<break/><related-object link-type="booklink" source-id="gene" document-id="merrf" document-type="chapter">MERRF</related-object> (m.8344A&#x0003e;G, m.8356T&#x0003e;C)<break/>Chronic progressive external ophthalmoplegia (m.3243A&#x0003e;G, m.4274T&#x0003e;C)<break/>Myopathy (m.14709T&#x0003e;C, m.12320A&#x0003e;G)<break/>Cardiomyopathy (m.3243A&#x0003e;G, m.4269A&#x0003e;G)<break/>Diabetes and deafness (m.3243A&#x0003e;G, m.12258C&#x0003e;A)<break/>Encephalomyopathy (m.1606G&#x0003e;A, m.10010T&#x0003e;C)<break/><related-object link-type="booklink" source-id="gene" document-id="mt-deafness" document-type="chapter">Nonsyndromic sensorineural deafness</related-object> (m.7445A&#x0003e;G)</td>
              </tr>
              <tr>
                <td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>rRNA genes&#x000a0;<sup>1</sup></bold>
                </td>
                <td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Aminoglycoside-induced nonsyndromic deafness (m.1555A&#x0003e;G)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For the genetic code, gene structure, and other features of the mitochondrial genome see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.mitomap.org/MITOMAP">MITOMAP: A Human Mitochondrial Genome Database</ext-link>. Variants are named according to current nomenclature guidelines (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). The reference sequence for the human mitochondrial DNA is NC_012920.1 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.mitomap.org">www.mitomap.org</ext-link>).</p>
            </fn>
            <fn id="mt-overview.TF.3b.1">
              <label>1. </label>
              <p>Mitochondrial DNA nucleotide positions refer to the L-chain.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="mt-overview.Establishing_the_Diagnosis_o">
        <title>Establishing the Diagnosis of a Mitochondrial Disorder</title>
        <p>Mitochondrial dysfunction should be considered in the differential diagnosis of any progressive multisystem disorder. A full evaluation for a mitochondrial disorder is often warranted in children with a complex neurologic picture or a single neurologic symptom and other system involvement.</p>
        <p>Findings that can suggest a mitochondrial disorder include clinical phenotype (physical examination including neurologic examination), mode of inheritance (family history), and extent of the phenotype (biochemical and histologic findings). Molecular genetic testing of DNA extracted from a blood sample is used to establish the diagnosis.</p>
        <sec id="mt-overview.Physical_Examination_and_Neu">
          <title>Physical Examination and Neurologic Evaluation</title>
          <p><bold>Approach when a specific diagnosis is suspected.</bold> Establishing the diagnosis of a specific inherited disorder that affects mitochondrial function can be relatively straightforward if a person has a recognizable phenotype (<xref ref-type="table" rid="mt-overview.T.clinical_syndromes_of_mito">Table 1</xref>) that is supported by the family history and if molecular genetic testing of a single gene based on these phenotypic findings identifies a known pathogenic variant in the gene of interest.</p>
          <list list-type="bullet">
            <list-item>
              <p>When the clinical picture is classic for a nuclear DNA-inherited syndrome (<xref ref-type="table" rid="mt-overview.T.genetic_classification_of">Table 3a</xref>) and the gene is known (e.g., <related-object link-type="booklink" source-id="gene" document-id="mngie" document-type="chapter">mitochondrial neurogastrointestinal encephalomyopathy</related-object>, autosomal PEO with multiple secondary deletions, or a classic <related-object link-type="booklink" source-id="gene" document-id="alpers" document-type="chapter"><italic toggle="yes">POLG</italic>-related disorder</related-object> [including MIRAS and Alpers-Huttenlocher syndrome]) the clinician should proceed with molecular genetic studies (see <xref ref-type="sec" rid="mt-overview.Molecular_Genetic_Testing">Molecular Genetic Testing</xref>).</p>
            </list-item>
            <list-item>
              <p>When the presentation is classic for a maternally (mitochondrial) inherited mitochondrial syndrome such as <related-object link-type="booklink" source-id="gene" document-id="melas" document-type="chapter">MELAS</related-object>, <related-object link-type="booklink" source-id="gene" document-id="merrf" document-type="chapter">MERRF</related-object>, or <related-object link-type="booklink" source-id="gene" document-id="lhon" document-type="chapter">Leber hereditary optic neuropathy</related-object> (<xref ref-type="table" rid="mt-overview.T.genetic_classification_of_1">Table 3b</xref>), appropriate mtDNA studies should be obtained first (see <xref ref-type="sec" rid="mt-overview.Molecular_Genetic_Testing">Molecular Genetic Testing</xref>).</p>
            </list-item>
          </list>
        </sec>
        <sec id="mt-overview.Family_History">
          <title>Family History</title>
          <p>A three-generation family history can suggest a mode of inheritance and/or a diagnosis and can help in directing molecular genetic testing.</p>
          <sec id="mt-overview.Mode_of_Inheritance">
            <title>Mode of Inheritance</title>
            <p><bold>Mitochondrial inheritance</bold> (<xref ref-type="table" rid="mt-overview.T.genetic_classification_of_1">Table 3b</xref>). A family history in which males and females are affected, affected females transmit the disease to all their children, and affected males do not transmit the disease to their children suggests mitochondrial inheritance.</p>
            <p>The range of clinical features associated with mtDNA mutation is broad and the family history may include many oligosymptomatic family members (e.g., some with diabetes mellitus or mild sensorineural deafness as the only feature).</p>
            <p><bold>Autosomal recessive inheritance</bold> (<xref ref-type="table" rid="mt-overview.T.genetic_classification_of">Table 3a</xref>). A family history in which only sibs are affected (i.e., a single generation in the family) and/or when the parents are consanguineous suggests autosomal recessive inheritance.</p>
            <p><bold>Autosomal dominant inheritance</bold> (<xref ref-type="table" rid="mt-overview.T.genetic_classification_of">Table 3a</xref>). A family history in which males and females in multiple generations are affected suggests autosomal dominant inheritance.</p>
            <p>A clear autosomal dominant pattern of inheritance may be seen in individuals with PEO.</p>
            <p><bold>X-linked inheritance</bold>. A family history in which affected individuals are male and are related to each other through females suggests X-linked inheritance.</p>
            <p><bold>Simplex case.</bold> If only one member of a family is known to be affected, possibilities to consider are <italic toggle="yes">de novo</italic> mutation, decreased penetrance of a pathogenic variant associated with an autosomal dominant mitochondrial disorder, a single occurrence of an autosomal recessive or an X-linked disorder in a family, or an acquired (non-genetic) cause.</p>
            <list list-type="bullet">
              <list-item>
                <p>Most adults with PEO or KSS represent simplex cases.</p>
              </list-item>
              <list-item>
                <p>Many individuals with a childhood-onset encephalomyopathy represent simplex cases which may be caused by the presence of biallelic pathogenic variants in a nuclear gene or a mtDNA pathogenic variant.</p>
              </list-item>
            </list>
            <p>See the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK5191/"><italic toggle="yes">GeneReviews</italic> Glossary</ext-link> for more discussion of mitochondrial, autosomal recessive, autosomal dominant, and X-linked patterns of inheritance.</p>
            <p><bold>Approach when a mitochondrial disorder is suspected, but clinical findings do not suggest a specific diagnosis.</bold> The difficulty arises when no pathogenic variant is identified (despite suspicion of a specific disorder) or when the clinical abnormalities are complex and not easily matched to those of more common mitochondrial disorders.</p>
            <p>Clinical tests are used to support a diagnosis of mitochondrial disease [<xref ref-type="bibr" rid="mt-overview.REF.kaufmann.2009.85">Kaufmann et al 2009</xref>].</p>
          </sec>
        </sec>
        <sec id="mt-overview.Other_Investigations_to_Esta">
          <title>Other Investigations to Establish the Extent of the Phenotype</title>
          <p>When the clinical picture is nonspecific but highly suggestive of a mitochondrial disorder, the clinician should start with measurement of plasma or CSF lactic acid concentration, ketone bodies, plasma acylcarnitines, and urinary organic acids.</p>
          <p>
            <bold>Plasma/CSF Lactate/pyruvate</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Measurement of plasma lactate concentration is indicated in individuals with features of a myopathy or CNS disease. Fasting blood lactate concentrations above 3 mm/L support a diagnosis of mitochondrial disease.</p>
            </list-item>
            <list-item>
              <p>Measurement of CSF lactate concentration is indicated in individuals with suspected CNS disease. Fasting CSF lactate concentrations above 1.5 mm/L support a diagnosis of mitochondrial disease.</p>
              <p>Note: Normal plasma or CSF lactic acid concentration does not exclude the presence of a mitochondrial disorder.</p>
            </list-item>
          </list>
          <p><bold>Magnetic resonance spectroscopy and exercise testing</bold> may also be of use to detect an elevated lactate level in brain or muscle at rest, or a delay in the recovery of the ATP peak in muscle after exercise.</p>
          <p><bold>Neuroimaging</bold> is indicated in individuals with suspected CNS disease. CT may show basal ganglia calcification and/or diffuse atrophy. MRI may show focal atrophy of the cortex or cerebellum, or high signal change on T<sub>2</sub>-weighted images, particularly in the occipital cortex [<xref ref-type="bibr" rid="mt-overview.REF.scaglia.2005.1675">Scaglia et al 2005</xref>]. There may also be evidence of a generalized leukoencephalopathy [<xref ref-type="bibr" rid="mt-overview.REF.barrag_ncampos.2005.737">Barrag&#x000e1;n-Campos et al 2005</xref>]. Cerebellar atrophy is a prominent feature in children [<xref ref-type="bibr" rid="mt-overview.REF.scaglia.2005.1675">Scaglia et al 2005</xref>].</p>
          <p>
            <bold>Neurophysiologic studies</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Electroencephalography (EEG) is indicated in individuals with suspected encephalopathy or seizures. Encephalopathy may be associated with generalized slow wave activity on the EEG. Generalized or focal spike and wave discharges may be seen in individuals with seizures.</p>
            </list-item>
            <list-item>
              <p>Peripheral neurophysiologic studies are indicated in individuals with limb weakness, sensory symptoms, or areflexia. Electromyography (EMG) is often normal but may show myopathic features. Nerve conduction velocity (NCV) may be normal or may show a predominantly axonal sensorimotor polyneuropathy.</p>
            </list-item>
            <list-item>
              <p>Magnetic resonance spectroscopy (MRS) and exercise testing (with measurement of blood concentration of lactate) may be used to detect evidence of abnormal mitochondrial function non-invasively.</p>
            </list-item>
          </list>
          <p><bold>Glucose.</bold> An elevated concentration of fasting blood glucose may indicate diabetes mellitus.</p>
          <p><bold>Cardiac.</bold> Both electrocardiography and echocardiography may indicate cardiac involvement (cardiomyopathy or atrioventricular conduction defects).</p>
        </sec>
        <sec id="mt-overview.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p>Establishing a molecular genetic diagnosis has important implications for the counseling of individuals with mitochondrial disease [<xref ref-type="bibr" rid="mt-overview.REF.lieber.2013.1762">Lieber et al 2013</xref>, <xref ref-type="bibr" rid="mt-overview.REF.nesbitt.2013.936">Nesbitt et al 2013</xref>]. For example, infantile cytochrome oxidase deficiency may be caused by biallelic pathogenic variants in the nuclear genes <italic toggle="yes">SURF1</italic> or <italic toggle="yes">SCO2</italic> or by a maternally inherited single nucleotide variant of mtDNA (e.g., m.8993T&#x0003e;G). CPEO may be caused by a <italic toggle="yes">de novo</italic> deletion (e.g., caused by a large deletion of mtDNA) or maternally inherited (e.g., the mtDNA m.3243A&#x0003e;G pathogenic variant).</p>
          <p>The ordering of molecular genetic tests and interpretation of results is complex and may require the support of an experienced laboratory, clinical geneticist, and genetic counselor.</p>
          <p>Molecular genetic testing may be carried out on genomic DNA extracted from blood (suspected nuclear DNA pathogenic variants and some pathogenic mtDNA variants) or on genomic DNA extracted from muscle (suspected pathogenic mtDNA variants).</p>
          <p>Approaches to molecular genetic testing of a proband to consider are serial testing of single genes, multi-gene panel testing (simultaneous testing of multiple genes), and genomic testing (e.g., sequencing the mitochondrial genome; exome sequencing or genome sequencing to identify a pathogenic variant in a nuclear gene).</p>
          <sec id="mt-overview.SingleGene_and_MultiGene_Pan">
            <title>Single-Gene and Multi-Gene Panel Testing</title>
            <p>In contrast to genomic testing, serial testing of single genes and multi-gene panel testing rely on the clinician developing a hypothesis about which specific gene or set of genes to test. Hypotheses may be based on (1) mode of inheritance, (2) distinguishing clinical features, and/or (3) other discriminating features.</p>
            <p><bold>Studies for pathogenic mtDNA variants</bold> are usually carried out on skeletal muscle DNA because a pathogenic mtDNA variant may not be detected in DNA extracted from blood.</p>
            <list list-type="bullet">
              <list-item>
                <p>Long-range PCR or quantitative PCR analysis may reveal a pathogenic mtDNA rearrangement. The deletion or duplication breakpoint may then be mapped by mtDNA sequencing.</p>
              </list-item>
              <list-item>
                <p>Targeted analysis for pathogenic variants featuring a panel of mitochondrial genes may be performed.</p>
              </list-item>
              <list-item>
                <p>If a recognized single nucleotide variant is not identified, the entire mitochondrial genome may be sequenced.</p>
              </list-item>
            </list>
            <p><bold>Studies for nuclear gene pathogenic variants.</bold> For multi-gene panels:</p>
            <list list-type="bullet">
              <list-item>
                <p>The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
              </list-item>
              <list-item>
                <p>The testing method used in some multi-gene panels may not detect mtDNA variants at low levels of heteroplasmy in blood, or mtDNA deletions and, therefore, would not be useful if a disorder (or disorders) caused by pathogenic mtDNA variants were suspected.</p>
              </list-item>
            </list>
          </sec>
          <sec id="mt-overview.Genomic_Testing">
            <title>Genomic Testing</title>
            <p>If single-gene testing (and/or use of a multi-gene panel) has not confirmed a diagnosis in an individual with features of a mitochondrial disorder, genomic testing may be considered. Such testing includes exome sequencing, genome sequencing, and mitochondrial sequencing.</p>
            <p>Note: (1) False negative rates vary by genomic region; therefore, genomic testing may not be as accurate as targeted single gene testing or multi-gene molecular genetic testing panels. (2) Most laboratories confirm positive results using a second, well-established method. (3) Certain DNA variants may not be detectible through genomic testing, such as large deletions or duplications (&#x0003e;8-10 bp in length), triplet repeat expansions, and epigenetic alterations [<xref ref-type="bibr" rid="mt-overview.REF.biesecker.2014.2418">Biesecker &#x00026; Green 2014</xref>].</p>
            <p>Exome sequencing has been shown to be very effective in defining the genetic basis of mitochondrial disorders caused by mutation of nuclear genes [<xref ref-type="bibr" rid="mt-overview.REF.taylor.2014.68">Taylor et al 2014</xref>]. To determine the molecular basis of multiple respiratory chain complex deficiencies, <xref ref-type="bibr" rid="mt-overview.REF.taylor.2014.68">Taylor et al [2014]</xref> studied 53 individuals who met the following criteria:</p>
            <list list-type="bullet">
              <list-item>
                <p>Evidence of histochemical and/or biochemical diagnosis of mitochondrial disease in a clinically affected tissue (skeletal muscle, liver, or heart) confirming decreased activities of multiple respiratory chain complexes based on published criteria</p>
              </list-item>
              <list-item>
                <p>Absence of large-scale mtDNA rearrangements, mtDNA depletion, and mtDNA single-nucleotide variants, in persons in whom decreased levels of mtDNA were confirmed in muscle (mtDNA depletion)</p>
              </list-item>
              <list-item>
                <p>Exclusion of major nuclear gene rearrangements by comparative genomic hybridization arrays in those with congenital structural abnormalities</p>
              </list-item>
            </list>
            <p>Of the 53 probands, presumptive causal variants were identified in 28 (53%; 95%CI, 39%-67%) and possible causal variants were identified in four (8%; 95%CI, 2%-18%). Together these accounted for 32 probands (60% 95%CI, 46%-74%) and involved 18 different genes.</p>
          </sec>
        </sec>
        <sec id="mt-overview.Other_NonMolecular_Genetic_T">
          <title>Other (Non-Molecular Genetic) Testing</title>
          <p>In many individuals in whom molecular genetic testing does not yield or confirm a diagnosis, further investigation of suspected mitochondrial disease can involve a range of different clinical tests, including muscle biopsy for respiratory chain function.</p>
        </sec>
      </sec>
      <sec id="mt-overview.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="mt-overview.Mode_of_Inheritance_1">
          <title>Mode of Inheritance</title>
          <p>Mitochondrial disorders may be caused by mutation of a mtDNA gene or mutation of a nuclear gene.</p>
          <list list-type="bullet">
            <list-item>
              <p>Mitochondrial DNA variants are transmitted by maternal inheritance (mitochondrial inheritance) [<xref ref-type="bibr" rid="mt-overview.REF.thorburn.2001.102">Thorburn &#x00026; Dahl 2001</xref>].</p>
            </list-item>
            <list-item>
              <p>Nuclear gene variants may be inherited in an autosomal recessive, autosomal dominant, or X-linked manner.</p>
            </list-item>
          </list>
        </sec>
        <sec id="mt-overview.Risk_to_Family_Members__Mito">
          <title>Risk to Family Members &#x02014; Mitochondrial Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Single mtDNA deletions</p>
              <list list-type="bullet">
                <list-item>
                  <p>Mitochondrial DNA deletions generally occur <italic toggle="yes">de novo</italic> and thus affect only one family member.</p>
                </list-item>
                <list-item>
                  <p>When single mtDNA deletions are transmitted, inheritance is from the mother.</p>
                </list-item>
                <list-item>
                  <p>The predisposition to form multiple mtDNA deletions can be inherited as an autosomal dominant or an autosomal recessive trait.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Mitochondrial DNA single-nucleotide variants and duplications</p>
              <list list-type="bullet">
                <list-item>
                  <p>Mitochondrial DNA single-nucleotide variants and duplications may be transmitted through the maternal line.</p>
                </list-item>
                <list-item>
                  <p>The father of a proband is not at risk of having the mtDNA pathogenic variant.</p>
                </list-item>
                <list-item>
                  <p>The mother of a proband (usually) has the mtDNA pathogenic variant and may or may not have symptoms.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs depends on the genetic status of the mother: if the mother has the mtDNA pathogenic variant, all sibs are at risk of inheriting it.</p>
            </list-item>
            <list-item>
              <p>When a proband has a single mtDNA deletion, the current best estimate of the recurrence risk to sibs is 1/24 [<xref ref-type="bibr" rid="mt-overview.REF.chinnery.2004.592">Chinnery et al 2004</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Offspring of males with a mtDNA pathogenic variant will not inherit the variant.</p>
            </list-item>
            <list-item>
              <p>All offspring of females with a mtDNA pathogenic variant are at risk of inheriting the pathogenic variant.</p>
              <list list-type="bullet">
                <list-item>
                  <p>A female harboring a heteroplasmic mtDNA single nucleotide variant may transmit a variable amount of mutated mtDNA to her offspring, resulting in considerable clinical variability among sibs within the same nuclear family [<xref ref-type="bibr" rid="mt-overview.REF.poulton.2000.460">Poulton &#x00026; Turnbull 2000</xref>].</p>
                </list-item>
                <list-item>
                  <p>For the m.8993T&#x0003e;G, m.8993T&#x0003e;C, m.3243A&#x0003e;G, m.8344A&#x0003e;G, and m.11778G&#x0003e;A mtDNA pathogenic variants, the risk of having clinically affected offspring appears to be related to the percentage level of mutated mtDNA in the mother's blood [<xref ref-type="bibr" rid="mt-overview.REF.chinnery.1998.1889">Chinnery et al 1998</xref>, <xref ref-type="bibr" rid="mt-overview.REF.white.1999a.474">White et al 1999a</xref>, <xref ref-type="bibr" rid="mt-overview.REF.chinnery.2001.235">Chinnery et al 2001</xref>]. However, these data were obtained retrospectively and should not be directly used for genetic counseling.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the genetic status of the proband's mother: if she has a mtDNA pathogenic variant, her sibs and mother are also at risk.</p>
        </sec>
        <sec id="mt-overview.Risk_to_Family_Members__Auto">
          <title>Risk to Family Members &#x02014; Autosomal Recessive Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes and therefore each carry one pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, the sibs of an affected individual have a 25% chance of inheriting both pathogenic variants and being affected, a 50% chance of inheriting one pathogenic variant and being a carrier, and a 25% chance of inheriting both normal alleles and being unaffected.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> All offspring are obligate heterozygotes.</p>
        </sec>
        <sec id="mt-overview.Risk_to_Family_Members__Auto_1">
          <title>Risk to Family Members &#x02014; Autosomal Dominant Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>One parent of the proband may have the same pathogenic variant as the proband; that parent may or may not have symptoms.</p>
            </list-item>
            <list-item>
              <p>A proband may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by a <italic toggle="yes">de novo</italic> pathogenic variant is unknown.</p>
            </list-item>
          </list>
          <p>Note: The family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent.</p>
          <p><bold>Sibs of a proband.</bold> The risk to the sibs depends on the genetic status of the parents: if one parent has the same pathogenic variant, the risk to the sibs is 50%.</p>
          <p><bold>Offspring of a proband.</bold> Each offspring of a proband has a 50% chance of inheriting the pathogenic variant.</p>
        </sec>
        <sec id="mt-overview.Risk_to_Family_Members__XLin">
          <title>Risk to Family Members &#x02014; X-Linked Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The father of an affected male will not have the disease nor will he be a carrier of the pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>Women who have an affected son and another affected male relative are obligate heterozygotes.</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband.</bold> The risk to sibs depends on the carrier status of the mother:</p>
          <list list-type="bullet">
            <list-item>
              <p>If the mother of the proband has a pathogenic variant, the chance of transmitting it in each pregnancy is 50%. Male sibs who inherit the pathogenic variant will be affected; female sibs who inherit the pathogenic variant will be carriers and will usually not be affected.</p>
            </list-item>
            <list-item>
              <p>If the proband represents a simplex case (i.e., a single occurrence in a family) and if the pathogenic variant cannot be detected in the leukocyte DNA of the mother, the risk to sibs is low but greater than that of the general population because of the possibility of maternal germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> All the daughters of an affected male are carriers; none of his sons will be affected.</p>
        </sec>
        <sec id="mt-overview.Related_Genetic_Counseling_I">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="mt-overview.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p><bold>Mutation of mitochondrial DNA (mtDNA).</bold> Prenatal molecular genetic testing and interpretation for mtDNA disorders is difficult because of mtDNA heteroplasmy. The percentage level of mutated mtDNA in a chorionic villus sampling (CVS) biopsy may not reflect the percentage level of mutated mtDNA in other fetal tissues, and the percentage level may change during development and throughout life [<xref ref-type="bibr" rid="mt-overview.REF.hellebrekers.2012.341">Hellebrekers et al 2012</xref>].</p>
          <p>The interpretation of a CVS result is difficult for most heteroplasmic mtDNA pathogenic variants. However, the variants m.8993T&#x0003e;G and m.8993T&#x0003e;C show a more even tissue distribution and the percentage level of these two variants does not appear to change significantly over time [<xref ref-type="bibr" rid="mt-overview.REF.white.1999b.899">White et al 1999b</xref>]. Successful prenatal molecular diagnosis has been carried out for these two pathogenic variants [<xref ref-type="bibr" rid="mt-overview.REF.harding.1992.629">Harding et al 1992</xref>, <xref ref-type="bibr" rid="mt-overview.REF.white.1999a.474">White et al 1999a</xref>] using DNA extracted from fetal cells obtained by amniocentesis (usually performed at ~15-18 weeks' gestation) or CVS (usually performed at ~10-12 weeks' gestation) [<xref ref-type="bibr" rid="mt-overview.REF.hellebrekers.2012.341">Hellebrekers et al 2012</xref>].</p>
          <p>
            <bold>Mutation of nuclear DNA</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Molecular genetic testing.</bold> If the pathogenic variant(s) have been identified in an affected family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing of this gene or custom prenatal testing.</p>
            </list-item>
            <list-item>
              <p><bold>Biochemical genetic testing.</bold> Once the specific biochemical abnormality has been identified in an affected family member, prenatal biochemical testing for pregnancies at risk for respiratory chain complex defects is possible using biochemical testing of cultured amniocytes obtained from amniocentesis usually performed at about 15 to 18 weeks' gestation [<xref ref-type="bibr" rid="mt-overview.REF.poulton.2000.460">Poulton &#x00026; Turnbull 2000</xref>].</p>
            </list-item>
          </list>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the pathogenic variant(s) have been identified.</p>
        </sec>
      </sec>
      <sec id="mt-overview.Resources">
        <title>Resources</title>
      </sec>
      <sec id="mt-overview.Management">
        <title>Management</title>
        <sec id="mt-overview.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The management of mitochondrial disease is largely supportive [<xref ref-type="bibr" rid="mt-overview.REF.chinnery.2001.94">Chinnery &#x00026; Turnbull 2001</xref>]. The clinician must have a thorough knowledge of the potential complications of mitochondrial disorders to prevent unnecessary morbidity and mortality.</p>
          <p>Management issues may include early diagnosis and treatment of diabetes mellitus, cardiac pacing, ptosis correction, intraocular lens replacement for cataracts, and cochlear implantation for sensorineural hearing loss.</p>
          <p>A variety of vitamins and co-factors have been used in individuals with mitochondrial disorders, although a Cochrane systematic review has shown that evidence supporting their use is lacking [<xref ref-type="bibr" rid="mt-overview.REF.chinnery.2006.cd004426">Chinnery et al 2006</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>Food supplements such as ubiquinone (coenzyme Q<sub>10</sub>, ubidecarenone) are generally well tolerated and some individuals report a subjective benefit on treatment.</p>
            </list-item>
            <list-item>
              <p>Individuals with complex I and/or complex II deficiency may benefit from oral administration of riboflavin.</p>
            </list-item>
          </list>
          <p>The role of exercise therapy in mitochondrial myopathy is currently being evaluated [<xref ref-type="bibr" rid="mt-overview.REF.taivassalo.2001.133">Taivassalo et al 2001</xref>, <xref ref-type="bibr" rid="mt-overview.REF.taivassalo.2006.3391">Taivassalo et al 2006</xref>, <xref ref-type="bibr" rid="mt-overview.REF.murphy.2008.2832">Murphy et al 2008</xref>].</p>
          <p>Coenzyme Q<sub>10</sub> is specifically indicated in persons with defects of CoQ<sub>10</sub> biosynthesis.</p>
          <p>Idebenone shows promise for the treatment of <related-object link-type="booklink" source-id="gene" document-id="lhon" document-type="chapter">Leber hereditary optic neuropathy</related-object>.</p>
          <p>Some secondary causes of mitochondrial dysfunction, such as <related-object link-type="booklink" source-id="gene" document-id="ee" document-type="chapter">ethylmalonic aciduria</related-object>, may have specific treatments [<xref ref-type="bibr" rid="mt-overview.REF.tiranti.2009.200">Tiranti et al 2009</xref>].</p>
          <p>Those with <related-object link-type="booklink" source-id="gene" document-id="mngie" document-type="chapter">mitochondrial neurogastrointestinal encephalomyopathy</related-object> (MNGIE) may benefit from hematopoietic stem cell transplantation.</p>
        </sec>
        <sec id="mt-overview.Prevention_Strategies_Under">
          <title>Prevention Strategies Under Investigation</title>
          <p>The possibility of nuclear transfer as a means of preventing transmission of pathogenic mtDNA variants is currently being explored [<xref ref-type="bibr" rid="mt-overview.REF.craven.2010.82">Craven et al 2010</xref>].</p>
        </sec>
      </sec>
      <sec id="mt-overview.References">
        <title>References</title>
        <sec id="mt-overview.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="mt-overview.Literature_Cited.reflist0">
            <ref id="mt-overview.REF.arpa.2003.690">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arpa</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cruz-Martinez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campos</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutierrez-Molina</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Rio</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez-Conde</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubio</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Hoyo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arpa-Fernandez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arenas</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Prevalence and progression of mitochondrial diseases: a study of 50 patients.</article-title>
                <source>Muscle Nerve</source>
                <volume>28</volume>
                <fpage>690</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">14639582</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.barrag_ncampos.2005.737">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barrag&#x000e1;n-Campos</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vallee</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrera-Ramirez</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Argote-Greene</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanchez-Guerrero</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Estanol</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guillevin</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiras</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Brain magnetic resonance imaging findings in patients with mitochondrial cytopathies.</article-title>
                <source>Arch Neurol</source>
                <volume>62</volume>
                <fpage>737</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">15883260</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.biesecker.2014.2418">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Biesecker</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>RC</given-names>
                  </name>
                </person-group>
                <article-title>Diagnostic clinical genome and exome sequencing.</article-title>
                <source>N Engl J Med.</source>
                <year>2014</year>
                <month>Jun</month>
                <day>19</day>
                <volume>370</volume>
                <issue>25</issue>
                <fpage>2418</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">24941179</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.casari.1998.973">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Casari</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Fusco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciarmatori</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mora</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandez</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Michele</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filla</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cocozza</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marconi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000fc;rr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontaine</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballabio</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease.</article-title>
                <source>Cell.</source>
                <volume>93</volume>
                <fpage>973</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">9635427</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.chinnery.2001.235">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howell</surname>
                    <given-names>NN</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Leber hereditary optic neuropathy: Does heteroplasmy influence the inheritance and expression of the G11778A mitochondrial DNA mutation?</article-title>
                <source>Am J Med Genet</source>
                <volume>98</volume>
                <fpage>235</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">11169561</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.chinnery.2004.592">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schon</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mariotti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lombes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laforet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogier</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaksch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deschauer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thorburn</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bindoff</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poulton</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthews</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Risk of developing a mitochondrial DNA deletion disorder.</article-title>
                <source>Lancet.</source>
                <volume>364</volume>
                <fpage>592</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15313359</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.chinnery.1998.1889">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howell</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lightowlers</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>MELAS and MERRF. The relationship between maternal mutation load and the frequency of clinically affected offspring.</article-title>
                <source>Brain.</source>
                <volume>121</volume>
                <fpage>1889</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">9798744</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.chinnery.2000.188">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wardell</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singh-Kler</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayes</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bindoff</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>The epidemiology of pathogenic mitochondrial DNA mutations.</article-title>
                <source>Ann Neurol</source>
                <volume>48</volume>
                <fpage>188</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">10939569</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.chinnery.2006.cd004426">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majamaa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thorburn</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Treatment for mitochondrial disorders.</article-title>
                <source>Cochrane Database Syst Rev</source>
                <volume>1</volume>
                <fpage>CD004426</fpage>
                <pub-id pub-id-type="pmid">16437486</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.chinnery.2001.94">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Epidemiology and treatment of mitochondrial disorders.</article-title>
                <source>Am J Med Genet</source>
                <volume>106</volume>
                <fpage>94</fpage>
                <lpage>101</lpage>
                <pub-id pub-id-type="pmid">11579428</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.ciafaloni.1993.419">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ciafaloni</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santorelli</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deonna</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roulet</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janzer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pescia</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Maternally inherited Leigh syndrome.</article-title>
                <source>J Pediatr</source>
                <volume>122</volume>
                <fpage>419</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">8095070</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.craven.2010.82">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Craven</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuppen</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greggains</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harbottle</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cree</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murdoch</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lightowlers</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herbert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease.</article-title>
                <source>Nature.</source>
                <volume>465</volume>
                <fpage>82</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">20393463</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.darin.2001.377">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Darin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oldfors</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moslemi</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holme</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tulinius</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA anbormalities.</article-title>
                <source>Ann Neurol</source>
                <volume>49</volume>
                <fpage>377</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">11261513</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.dimauro.2001.18">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schon</surname>
                    <given-names>EA</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Mitochondrial DNA mutations in human disease.</article-title>
                <source>Am J Med Genet</source>
                <volume>106</volume>
                <fpage>18</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">11579421</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.hammans.1993.617">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hammans</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweeney</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockington</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lennox</surname>
                    <given-names>GG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lawton</surname>
                    <given-names>NF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennedy</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan-Hughes</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>The mitochondrial DNA transfer RNA(Lys)A--&#x0003e;G(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA.</article-title>
                <source>Brain</source>
                <volume>116</volume>
                <fpage>617</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">8513395</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.harding.1992.629">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holt</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweeney</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockington</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>MB</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Prenatal diagnosis of mitochondrial DNA8993 T----G disease.</article-title>
                <source>Am J Hum Genet</source>
                <volume>50</volume>
                <fpage>629</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">1539598</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.hellebrekers.2012.341">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hellebrekers</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolfe</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hendrickx</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Coo</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Die</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geraedts</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smeets</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <article-title>PGD and heteroplasmic mitochondrial DNA point mutations: a systematic review estimating the chance of healthy offspring.</article-title>
                <source>Human Reproduction Update</source>
                <year>2012</year>
                <volume>18</volume>
                <fpage>341</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">22456975</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.hirano.1992.125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricci</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenigsberger</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Defendini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavlakis</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeVivo</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rowland</surname>
                    <given-names>LP</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Melas: an original case and clinical criteria for diagnosis.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>2</volume>
                <fpage>125</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">1422200</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.holt.1988.717">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holt</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan-Hughes</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>1988</year>
                <article-title>Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies.</article-title>
                <source>Nature</source>
                <volume>331</volume>
                <fpage>717</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">2830540</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.holt.1990.428">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holt</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petty</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan-Hughes</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>1990</year>
                <article-title>A new mitochondrial disease associated with mitochondrial DNA heteroplasmy.</article-title>
                <source>Am J Hum Genet</source>
                <volume>46</volume>
                <fpage>428</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">2137962</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.kaufmann.2009.85">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaufmann</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wei</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kulikova</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oskoui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battista</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenigsberger</surname>
                    <given-names>DY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shungu</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <article-title>Protean phenotypic features of the A3243G mitochondrial DNA mutation.</article-title>
                <source>Arch Neurol.</source>
                <year>2009</year>
                <volume>66</volume>
                <fpage>85</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">19139304</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.koopman.2012.1132">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koopman</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willems</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smeitink</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Monogenic mitochondrial disorders.</article-title>
                <source>N Engl J Med.</source>
                <year>2012</year>
                <volume>366</volume>
                <fpage>1132</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">22435372</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.larsson.1995.151">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Larsson</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clayton</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Molecular genetic aspects of human mitochondrial disorders.</article-title>
                <source>Annu Rev Genet</source>
                <volume>29</volume>
                <fpage>151</fpage>
                <lpage>78</lpage>
                <pub-id pub-id-type="pmid">8825472</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.leonard.2000a.299">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schapira</surname>
                    <given-names>AVH</given-names>
                  </name>
                </person-group>
                <year>2000a</year>
                <article-title>Mitochondrial respiratory chain disorders I: mitochondrial DNA defects.</article-title>
                <source>Lancet</source>
                <volume>355</volume>
                <fpage>299</fpage>
                <lpage>304</lpage>
                <pub-id pub-id-type="pmid">10675086</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.leonard.2000b.389">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schapira</surname>
                    <given-names>AVH</given-names>
                  </name>
                </person-group>
                <year>2000b</year>
                <article-title>Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects.</article-title>
                <source>Lancet</source>
                <volume>355</volume>
                <fpage>389</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">10665569</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.lieber.2013.1762">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lieber</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calvo</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanahan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slate</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hershman</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gold</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thorburn</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berry</surname>
                    <given-names>GT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmahmann</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borowsky</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mueller</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sims</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mootha</surname>
                    <given-names>VK</given-names>
                  </name>
                </person-group>
                <article-title>Targeted exome sequencing of suspected mitochondrial disorders.</article-title>
                <source>Neurology.</source>
                <year>2013</year>
                <volume>80</volume>
                <fpage>1762</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">23596069</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.lutsenko.1998.6004">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lutsenko</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooper</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Localization of the Wilson's disease protein product to mitochondria.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <volume>95</volume>
                <fpage>6004</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9600907</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.macmillan.1993.1586">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Macmillan</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lach</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoubridge</surname>
                    <given-names>EA</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Variable distribution of mutant mitochondrial DNAs (tRNA(Leu[3243])) in tissues of symptomatic relatives with MELAS: the role of mitotic segregation.</article-title>
                <source>Neurology</source>
                <volume>43</volume>
                <fpage>1586</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">8351017</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.majamaa.1998.447">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Majamaa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moilanen</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uimonen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Remes</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salmela</surname>
                    <given-names>PI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karppa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majamaa-Voltti</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rusanen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorri</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peuhkurinen</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hassinen</surname>
                    <given-names>IE</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population.</article-title>
                <source>Am J Hum Genet</source>
                <volume>63</volume>
                <fpage>447</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">9683591</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.moraes.1989.1293">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moraes</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lombes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miranda</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakase</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Werneck</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Servidei</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koga</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spiro</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brownell</surname>
                    <given-names>AKW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schotland</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zupanc</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeVivo</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schon</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rowland</surname>
                    <given-names>LP</given-names>
                  </name>
                </person-group>
                <year>1989</year>
                <article-title>Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome.</article-title>
                <source>N Engl J Med</source>
                <volume>320</volume>
                <fpage>1293</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">2541333</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.morat_.2014.1878">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morat&#x000f3;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verrigni</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ardissone</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uziel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pujol</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Mitochondrial dysfunction in central nervous system white matter disorders.</article-title>
                <source>Glia.</source>
                <year>2014</year>
                <volume>62</volume>
                <fpage>1878</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">24865954</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.murphy.2008.2832">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blakely</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaefer</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wyrick</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haller</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taivassalo</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Resistance training in patients with single, large-scale deletions of mitochondrial DNA.</article-title>
                <source>Brain.</source>
                <year>2008</year>
                <volume>131</volume>
                <fpage>2832</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">18984605</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.munnich.2001.4">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rustin</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Clinical spectrum and diagnosis of mitochondrial disorders.</article-title>
                <source>Am J Med Genet</source>
                <volume>106</volume>
                <fpage>4</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">11579420</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.nelson.1995.400">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanna</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alsanjari</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scaravilli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan-Hughes</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>A new mitochondrial DNA mutation associated with progressive dementia and chorea: a clinical, pathological, and molecular genetic study.</article-title>
                <source>Ann Neurol</source>
                <volume>37</volume>
                <fpage>400</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">7695240</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.nesbitt.2013.936">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nesbitt</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pitceathly</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweeney</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mudanohwo</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanna</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McFarland</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A&#x0003e;G mutation--implications for diagnosis and management.</article-title>
                <source>J Neurol Neurosurg Psychiatry.</source>
                <year>2013</year>
                <volume>84</volume>
                <fpage>936</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23355809</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.poulton.2000.460">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Poulton</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>74th ENMC International workshop: mitochondrial diseases 19-20 November 1999, Naarden, the Netherlands.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>10</volume>
                <fpage>460</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">10899455</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.r_tig.1997.215">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>R&#x000f6;tig</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chretien</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foury</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenig</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sidi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rustin</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia.</article-title>
                <source>Nat Genet.</source>
                <volume>17</volume>
                <fpage>215</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9326946</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.scaglia.2005.1675">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scaglia</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vladutiu</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunter</surname>
                    <given-names>JV</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Predominant cerebellar volume loss as a neuroradiologic feature of pediatric respiratory chain defects.</article-title>
                <source>AJNR Am J Neuroradiol</source>
                <volume>26</volume>
                <fpage>1675</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">16091512</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.scarpelli.2013.520">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scarpelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricciardi</surname>
                    <given-names>GK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beltramello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zocca</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calabria</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russignan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zappini</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cotelli</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Padovani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomelleri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filosto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonin</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>The role of brain MRI in mitochondrial neurogastrointestinal encephalomyopathy.</article-title>
                <source>Neuroradiol J.</source>
                <year>2013</year>
                <volume>26</volume>
                <fpage>520</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">24199812</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.schon.1997.131">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schon</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Mitochondrial DNA mutations and pathogenesis.</article-title>
                <source>J Bioenerg Biomembr</source>
                <volume>29</volume>
                <fpage>131</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">9239539</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.skladal.2003.1905">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Skladal</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halliday</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thorburn</surname>
                    <given-names>DR</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Minimum birth prevalence of mitochondrial respiratory chain disorders in children.</article-title>
                <source>Brain</source>
                <volume>126</volume>
                <fpage>1905</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">12805096</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.taivassalo.2006.3391">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Taivassalo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardner</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaefer</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barron</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haller</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <article-title>Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions.</article-title>
                <source>Brain.</source>
                <year>2006</year>
                <volume>129</volume>
                <fpage>3391</fpage>
                <lpage>401</lpage>
                <pub-id pub-id-type="pmid">17085458</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.taivassalo.2001.133">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Taivassalo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoubridge</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennaway</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnold</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haller</surname>
                    <given-names>RG</given-names>
                  </name>
                </person-group>
                <article-title>Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical, and genetic effects.</article-title>
                <source>Ann Neurol.</source>
                <year>2001</year>
                <volume>50</volume>
                <fpage>133</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">11506394</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.tay.2004.950">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tay</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Association of mutations in SCO2, a cytochrome c oxidase assembly gene, with early fetal lethality.</article-title>
                <source>Arch Neurol</source>
                <volume>61</volume>
                <fpage>950</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">15210538</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.taylor.2014.68">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pyle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blakely</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duff</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smertenko</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alston</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neeve</surname>
                    <given-names>VC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Best</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yarham</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schara</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talim</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topaloglu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baric</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holinski-Feder</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Czermin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleinle</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vassallo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorman</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramesh</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santibanez-Koref</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McFarland</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                </person-group>
                <article-title>Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies.</article-title>
                <source>JAMA</source>
                <year>2014</year>
                <volume>312</volume>
                <fpage>68</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">25058219</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.thorburn.2001.102">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thorburn</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahl</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Mitochondrial disorders: genetics, counseling, prenatal diagnosis and reproductive options.</article-title>
                <source>Am J Med Genet</source>
                <volume>106</volume>
                <fpage>102</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">11579429</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.tiranti.2009.200">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tiranti</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viscomi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hildebrandt</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Meo</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mineri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiveron</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levitt</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fagiolari</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rimoldi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy.</article-title>
                <source>Nat Med</source>
                <volume>15</volume>
                <fpage>200</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19136963</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.uziel.1997.16">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Uziel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moroni</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamantea</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fratta</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciceri</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Mitochondrial disease associated with the T8993G mutation of the mitochondrial ATPase 6 gene: a clinical, biochemical, and molecular study in six families.</article-title>
                <source>J Neurol Neurosurg Psychiatry.</source>
                <volume>63</volume>
                <fpage>16</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">9221962</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.van_den_ouweland.1992.368">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van den Ouweland</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lemkes</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruitenbeek</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandkuijl</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vijlder</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Struyvenberg</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van de Kamp</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maassen</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness.</article-title>
                <source>Nat Genet</source>
                <volume>1</volume>
                <fpage>368</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">1284550</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.wallace.1999.1482">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Mitochondrial diseases in man and mouse.</article-title>
                <source>Science</source>
                <volume>283</volume>
                <fpage>1482</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10066162</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.white.1999a.474">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>VR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolfe</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cleary</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahl</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thorburn</surname>
                    <given-names>DR</given-names>
                  </name>
                </person-group>
                <year>1999a</year>
                <article-title>Genetic counseling and prenatal diagnosis for the mitochondrial DNA mutations at nucleotide 8993.</article-title>
                <source>Am J Hum Genet</source>
                <volume>65</volume>
                <fpage>474</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">10417290</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.white.1999b.899">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGill</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mountain</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geraghty</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahl</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thorburn</surname>
                    <given-names>DR</given-names>
                  </name>
                </person-group>
                <year>1999b</year>
                <article-title>Mitochondrial DNA mutations at nucleotide 8993 show a lack of tissue- or age-related variation.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>22</volume>
                <fpage>899</fpage>
                <lpage>914</lpage>
                <pub-id pub-id-type="pmid">10604142</pub-id>
              </element-citation>
            </ref>
            <ref id="mt-overview.REF.wu.2016.1034">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peng</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deng</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lifen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yin</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Leukodystrophy associated with mitochondrial complex I deficiency due to a novel mutation in the NDUFAF1 gene.</article-title>
                <source>Mitochondrial DNA A DNA MappSeq Anal.</source>
                <year>2016</year>
                <volume>27</volume>
                <fpage>1034</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">24963768</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="mt-overview.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="mt-overview.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>14 August 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>16 September 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>18 December 2003 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>8 June 2000 (tk, pb) Overview posted to live Web site</p>
            </list-item>
            <list-item>
              <p>20 April 2000 (eh) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="mt-overview.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>The human mitochondrial genome</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mt-overview-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
